News
WGSWW
0.0300
-5.36%
-0.0017
Weekly Report: what happened at WGSWW last week (0506-0510)?
Weekly Report · 05/13 09:09
Weekly Report: what happened at WGSWW last week (0429-0503)?
Weekly Report · 05/06 09:10
GENEDX HOLDINGS SHARES UP 37.2% PREMARKET AFTER CO RAISES FY24 REV FORECAST
Reuters · 04/30 08:42
U.S. RESEARCH ROUNDUP-Domino's Pizza, HCA Healthcare, WW Grainger
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Domino's Pizza, HCA Healthcare, WW Grainger and Molina Healthcare among companies. Abbvie Inc. And others have seen their targets cut by some analysts.
Reuters · 04/30 07:05
GENEDX HOLDINGS CORP <WGS.O>: TD COWEN RAISES TARGET PRICE TO $24 FROM $14
Reuters · 04/30 04:28
GeneDx Holdings Corp reports results for the quarter ended in January - Earnings Summary
GeneDx Holdings Corp reports results for the quarter ended in January. Revenue rose 41.6% to $61.10 million from a year ago. The company reported a quarterly adjusted loss of 33 cents per share. Shares of the company have risen by 21.4% this quarter.
Reuters · 04/30 01:46
GeneDx Holdings Corp. Quarterly Report for the Period Ended March 31, 2024
Press release · 04/30 01:32
GENEDX HOLDINGS - ENTERED SALES AGREEMENT
Reuters · 04/29 21:13
GENEDX - CO MAY OFFER AND SELL SHARES OF CO’S CLASS A COMMON STOCK, HAVING AGGREGATE OFFERING PRICE OF UP TO $75.0 MLN
Reuters · 04/29 21:13
GENEDX REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
Reuters · 04/29 20:05
GENEDX HOLDINGS CORP - RAISED GUIDANCE TO DELIVER BETWEEN $235M AND $245M IN FY 2024 REVENUE AND REITERATE PATH TO PROFITABILITY IN 2025
Reuters · 04/29 20:05
Weekly Report: what happened at WGSWW last week (0422-0426)?
Weekly Report · 04/29 09:10
GeneDx Holdings Corp <WGS.OQ> expected to post a loss of 67 cents a share - Earnings Preview
GeneDx Holdings Corp expected to post a loss of 67 cents a share. The company is expected to report a 14.7% increase in quarterly revenue to $49.463 million. The average analyst estimate for the company's quarterly revenue is for a rise of 14.5%.
Reuters · 04/26 22:13
GENEDX ANNOUNCES PARTNERSHIP WITH KOMODO HEALTH TO EXPAND ACCESS TO WORLD’S LARGEST RARE DISEASE DATASET
Reuters · 04/23 12:30
Weekly Report: what happened at WGSWW last week (0415-0419)?
Weekly Report · 04/22 09:10
Weekly Report: what happened at WGSWW last week (0408-0412)?
Weekly Report · 04/15 09:09
Weekly Report: what happened at WGSWW last week (0401-0405)?
Weekly Report · 04/08 09:10
Weekly Report: what happened at WGSWW last week (0325-0329)?
Weekly Report · 04/01 09:10
Weekly Report: what happened at WGSWW last week (0318-0322)?
Weekly Report · 03/25 09:09
Weekly Report: what happened at WGSWW last week (0311-0315)?
Weekly Report · 03/18 09:10
More
Webull provides a variety of real-time WGSWW stock news. You can receive the latest news about GeneDx Holdings Corp through multiple platforms. This information may help you make smarter investment decisions.
About WGSWW
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.